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Interleukin 3 Have Overlapping but Distinct Hematopoietic Activities
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Departments of *Internal Medicine and Pediatrics, University ofMichigan Medical Center, Ann Arbor, Michigan 48109;
and tGenetics Institute, Cambridge, Massachusetts 02140

Abstract
The hematopoietic stimulatory activities of human recombinant IL-3 and granulocyte-macrophage colony stimulating factor (GM-CSF) were directly compared using highly enriched
human bone marrow progenitor target cells. IL-3 supported a
larger number of erythroid and megakaryocytic progenitor
cells than did GM-CSF, while GM-CSF supported more myeloid progenitors. IL-3 directly stimulated the division and migration of primitive erythroid burst forming units, while GMCSF merely sustained their net survival in culture without
promoting division and expansion. IL-3 promoted the formation of larger numbers of multipotential granulocyte-erythroid-macrophage-megakaryocyte colony forming unit-derived colonies than did GM-CSF. These data indicate that
human IL-3 and GM-CSF have overlapping but distinct hematopoietic activities, and suggest a potential role for the clinical
application of combined IL-3/GM-CSF therapy.

Introduction
Hematopoietic differentiation is a complex process in which
self-renewing pluripotent stem cells divide and evolve into
committed progenitor cells, recognizable precursor cells, and
finally mature blood cells. Although the factors that regulate
the earliest stages of stem cell differentiation are not well described, a family of proteins, termed hematopoietic growth
factors (HGFs),' stimulates the division and differentiation of
committed progenitor cells. This family includes two classes of
molecules. The first class stimulates committed progenitor
cells restricted to single lineages, and includes macrophage colony stimulating factor (1), granulocyte colony stimulating facAddress reprint requests to Dr. Stephen G. Emerson, The University of
Michigan Medical Center, MSRB I, Room 55 lOB, 1150 West Medical
Center Drive, Ann Arbor, MI 48109.
Receivedfor publication 22 September 1987 and in revisedform 18

tor (2), erythropoietin (Epo) (3), and perhaps thrombopoietin
(4). The second class of HGFs affects progenitors of several
lineages as well as more primitive multipotential progenitor
cells.
The first multipotent HGF isolated was granulocyte-macrophage colony stimulating factor (GM-CSF) (5). Picomolar
quantitives of GM-CSF provide colony stimulating activities
to granulocyte progenitors, macrophage progenitors, bipotent
granulocyte-macrophage progenitors, erythroid burst forming
units (BFU-E), and multipotential myeloid progenitors. GMCSF is active on progenitor cells from bone marrow, peripheral blood, and fetal liver (6-8).
Recently a cDNA has been cloned from the Gibbon leukemic cell line MLA-144 which encodes a second multipotent
HGF, IL-3 (9). The human genome contains a homologous
gene, whose predicted protein product differs from the gibbon
IL-3 protein by only nine amino acids. The gibbon protein is
active on human bone marrow progenitor cells (9), while the
activities of purified human IL-3 have yet to be defined.
In this study we examined the effects of human recombinant proteins IL-3 and GM-CSF on highly enriched human
progenitor cells. We show that while both hormones have
multilineage stimulating activities, their target cell specificities
are distinguishable. IL-3 supports the differentiation of a larger
number of erythroid and megakarocytic progenitor cells than
does GM-CSF, while GM-CSF supports more myeloid progenitors. IL-3 promotes BFU-E division, while GM-CSF appears to support BFU-E survival with little proliferation. In
addition, IL-3 promotes the formation of greater numbers of

multipotential granulocyte-erythroid-macrophage-megakaryocyte colony forming unit (CFU-GEMM)-derived colonies than does GM-CSF. These data support a model of differentiation in which the acquisition and loss of growth factor
responsiveness and lineage specific restriction are parallel but
asynchronous programs. In addition these data suggest a potential role for combined GM-CSF/IL-3 therapy in selected
clinical settings.

March 1988.

Methods

1. Abbreviations used in this paper: B1CM, bladder carcinoma 5637
conditional medium; BFU-E, erythroid burst-forming unit; CFUGEMM, granulocyte-erythroid-macrophage-megakaryocyte colony
forming unit; CFU-GM, granulocyte-macrophage colony forming
unit; CFU-Mk, megakaryocyte colony forming unit; Epo, erythropoietin; GM-CSF, human recombinant granulocyte-macrophage colony
stimulating factor; HGF, hematopoietic growth factor; IMDM,
Iscove's modified Dulbecco's medium; MoCM, Mo cell line conditional medium.

Bone marrow samples. Normal human bone marrow was obtained
following informed consent by aspiration into preservative-free heparin from adult volunteers, under a protocol approved by the University
of Michigan Human Investigation Committee.
Cell separation procedures. The marrow suspensions were centrifuged over Ficoll-Hypaque (1.077 g/cm3) (Pharmacia Fine Chemicals,
Piscataway, NJ) at 400 g for 40 min at 20'C, the interface mononuclear cells collected, washed three times, and resuspended in Iscove's
modified Dulbecco's medium (IMDM) containing 20% FCS. The cells
were incubated in 100-mm tissue culture dishes (Lux, Miles Laboratories, Elkhart, IN) overnight at 370C and the nonadherent cells removed
with two gentle washes and centrifuged.
Progenitor cell enrichment by panning. Nonadherent cells were
incubated with saturating quantities of a panel of eight murine mono-
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clonal antibodies for 1 h at 40C. The antibodies, their sources, specificities, and the quantities employed per 106 total nucleated cells were as
follows: anti-Leu-l (Becton-Dickinson & Co., Oxnard, CA), T cells,
100 ng; anti-Leu-5b (Becton-Dickinson & Co.), T cells and NK cells,
40 ng; anti-Leu-I0 (Becton-Dickinson & Co.), HLA-DQ, 400 ng; antiLeu-M 1 (Becton-Dickinson & Co.), mature and precursor myeloid
and monocytic cells, 200 ng; anti-Leu- 12 (Becton-Dickinson & Co.), B
cells, 200 ng; anti-CALLA (Becton-Dickinson & Co.), pre-B cells, 300
ng; TG- I (courtesy of Peter Beverley [10]), granulocytes, myeloid precursors, some monocytes, 5 Ml hybridoma supernatant; 4F7 (Laurence
Livermore Laboratories, Livermore, CA) glycophorin A, 1 Ml hybridoma supernatant. In some experiments 200 ng of Leu- 18 (anti My- I 1)
(Becton-Dickinson & Co.), which detects granulocyte-macrophage colony forming units (CFU-GM) and myeloid precursors, was also included. Antibody-coated cells were washed three times to remove excess antibody before panning. Separation of antibody-negative cells
(panning) was performed as previously described (6). Anti-Ig plates
were prepared by incubating 100 X 15-mm plastic culture plates (Lux)
with 5 ml affinity purified rabbit anti-mouse Ig (100 Mg/ml) in PBS
overnight at 4°C and washing with cold PBS before use. Coating the
plates with < 250 Mg antibody resulted in suboptimal cell binding.
Murine antibody-labeled, washed cells were suspended in 5 ml PBS at
1-5 X 107 cells/ml with 5% heat-inactivated FCS and incubated over
the rabbit anti-mouse Ig coated plates for 1 h at 4°C, after which time
the nonadherent, antibody negative cells were recovered by gently
pipetting without disrupting the antibody-coated cells bound to the
plates. Incubation times of < 40 min were ineffective at allowing maximal cell binding to the plates, while cells could be allowed to adhere to
the plates for at least 2 h without decreased binding or subsequent
plating efficiency. Panning removed 90-95% of bone marrow cells but
removed only 0-15% of the progenitor cells. Progenitor cells were
thereby concentrated 9-20-fold by the panning procedure.
Culture conditions. For most experiments, the bone marrow cells
were cultured in 0.9% methylcellulose in IMDM containing 30% FCS
(HyClone Laboratories, Logan, UT), 1% BSA (Sigma Chemical Co.,
St. Louis, MO), l0-4 M ,B-mercaptoethanol. The lot of FCS used was
chosen by comparison among six lots: the lot that supported maximal
colony growth in the presence of Epo + Mo cell line conditional
medium (MoCM), but none without Epo + MoCM, was selected.
GM-CSF, IL-3, or MoCM was added to the cultures at their initiation
(day 0), and erythropoietin was added on day 3. For liquid culture
experiments, bone marrow cells were initially incubated in IMDM
plus 20% FCS, with or without GM-CSF or IL-3, for 1-7 d before
plating in methylcellulose. Methylcellulose cultures were routinely established at 5,000-10,000 cells/ml in 0.33-ml triplicates in 24-well
tissue culture plates (Costar, Cambridge, MA) and incubated at 37°C
in a high humidity, 5% CO2 incubator.
Megakaryocyte cultures were performed as described for murine
cells (1 1, 12), except that 30% human plasma replaced the FCS. Briefly,
cells were cultured in supplemented McCoy's SA media containing
30% heparinized human plasma and 0.25% bactoagar (Difco, Detroit,
MI). Bone marrow cells were cocultivated with conditioned medium
from a human bladder carcinoma cell line (5637), IL-3, or GM-CSF.
Incubation conditions were identical to those for methylcellulose cultures. Megakaryocyte colonies were defined as greater than three cells/
colony and were identified by their morphological characteristics as
described elsewhere (I13-15).
BFU-E- and CFU-GM-derived colonies were counted on day 14,
and megakaryocyte colony forming unit (CFU-Mk)- and CFUGEMM-derived colonies were counted on day 17. CFU-GEMM-derived colonies were clearly distinguished from overlapping erythroid
and myeloid colonies by tracking the development of individual colonies over the 17-d culture. In addition, the frequency of CFUGEMM-derived colonies was unchanged in cell cultures plated over a
range from 1,000 to 20,000 cells per ml. For one series of experiments
total colonies and cell numbers per colony were counted on day 3, and
the numbers of subcolonies per BFU-E-derived colonies were counted
on day 14.

Hematopoietic growth factors. Purified recombinant erythropoietin (AmGen, Thousand Oaks, CA) was employed at 2 U per ml. Purified recombinant human GM-CSF (5) was generously provided by the
Genetics Institute Pilot Development Laboratory, and purified recombinant human IL-3 (9) was the generous gift of Dr. K. Turner and Dr.
R. Kaufman, Genetics Institute, Cambridge, MA. Both of these hematopoietins were produced from engineered Chinese hamster ovary
cells and had specific activities of 2-4 X 106 CML U/mg (9). MoCM
was prepared from the Mo T lymphoblast cell line (16). Human bladder carcinoma (5637) conditioned media (B1CM) (17) was obtained
from carcinoma cells grown in RPMI 1640 containing 0.75% (wt/vol)
glutamine (100X, Gibco Laboratories, Grand Island, NY) and 2%
FCS. Bladder carcinoma cells were cultured in 75-cm2 flasks on Cytodex-3 beads (Pharmacia Fine Chemicals), grown to confluence (on
beads), and media conditioned for 3-4 d. After centrifugation, the
B1CM was concentrated fivefold by ultrafiltration (YM-10 membrane,
Amicon Corp., Danvers, MA), filter sterilized, and stored at -80'C.

Results
Responsiveness of human hematopoietic progenitor cells to
IL-3. To accurately assess the effects of recombinant human
IL-3, we measured its activity on bone marrow cells that had
been physically and immunologically depleted of all known
accessory cells producing HGFs (6). This adherence and panning procedure, which concentrates progenitor cells 10-30fold, yields target cells that are totally dependent on added
HGFs for their survival, division, and differentiation. The addition of increasing concentrations of IL-3 to methylcellulose
cultures containing these enriched progenitor cells resulted in
a dose-dependent induction of erythroid, myeloid, and mixed
erythroid-myeloid colonies. For each lineage, maximal progenitor cell induction was seen at IL-3 concentrations of 2
ng/ml or higher (Fig. 1). This concentration was therefore used
in all subsequent experiments in assaying IL-3 effects.
Differential responsiveness of human progenitor cells to
IL-3 and GM-CSF. When assayed using enriched bone marrow progenitor cells, both recombinant human GM-CSF and
IL-3 supported erythroid, myeloid, and mixed erythroid-myeloid colonies. GM-CSF supported larger numbers of myeloid
colonies than did IL-3, though not as many as with 10%
MoCM (Table I). Both HGFs stimulate granulocyte, macro-oCu)
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Figure 1. Responsiveness of hematopoietic progenitor cells to IL-3.
Human bone marrow progenitor cells were enriched by panning as
described in Methods, and cultured in methylcellulose with Epo
added on day 3. BFU-E and CFU-GM-derived colonies were enumerated on day 14, and CFU-GEMM-derived colonies on day 17.
The data are means±SD from one of three similar experiments.
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Table I. Progenitor-derived Hematopoietic Colonies Supported
by IL-3 and GM-CSF
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30
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IL-3 (2 ng/ml)
GM-CSF (100 ng/ml)
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The data presented are means±SD from one of five similar experiments.
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phage, and mixed granulocyte-macrophage colony formation.
The cocultivation of GM-CSF and IL-3 gave no more myeloid
colonies than did GM-CSF alone.
In contrast to GM-CSF, IL-3 has a more pronounced effect
on early erythroid progenitor cells. In each of six experiments,
IL-3 (2 ng/ml) consistently yielded 50-400% more erythroid
bursts than did cultures containing as much as 300 ng/ml
GM-CSF. Additionally, IL-3 supports 20-50% more BFU-Ederived colonies than does 10% MoCM. As with granulocyte
progenitor cells, the combination of GM-CSF and IL-3 was
not additive for erythroid colony formation. Cultures containing IL-3 always yielded 20-100% more CFU-GEMM-derived
colonies than did cultures containing GM-CSF.

IL-3 induces the division and migration of primitive
BFU-E. The erythroid colonies induced by IL-3 appeared to
be somewhat larger and more multicentric than GM-CSF- or
MoCM-induced colonies. To further explore this difference,
individual erythroid colonies induced by GM-CSF or IL-3
were examined under a magnification of 300 using Hoffman
contrast optics, and the number of subcolonies constituting
each burst was measured. In cultures containing GM-CSF,
bursts ranged in composition from single unicentric colonies
to multicentric colonies with 35 subcolonies. Most of the colonies contained subcolonies, with mean = 10.4 subcolonies and
median = 9 subcolonies. The range of erythroid bursts induced
by IL-3 also included small unicentric colonies, but included
larger and more numerous multicentric colonies than did cultures containing GM-CSF (mean = 15.4 subcolonies, median
=14) (Fig. 2 A).
To focus on the proliferative effects of IL-3 and GM-CSF
on the earliest progeny of erythroid progenitor cells, BFU-Ederived clusters were examined after 3 d of culture. BFU-E
were enriched using an antibody cocktail containing anti-Leu
18 (18). This antibody bound to most CFU-GM, CFU-G, and
CFU-M as well as myeloid precursors, so that the great majority of colonies that developed were erythroid. Enriched progenitor cells were plated in methylcellulose in the presence of
IL-3 or GM-CSF. Individual clusters of cells were identified
and the numbers of cells per cluster enumerated on day 3 of
the cultures. Clusters induced by GM-CSF were generally
small, containing two to four cells. IL-3 induced not only similar small clusters, but also larger clusters containing six or
more cells (Fig. 2 B). These data suggested that IL-3 exerted a
stronger proliferative effect on BFU-E than did GM-CSF.
The effects of IL-3 and GM-CSF on BFU-E division were
directly compared by incubation of these factors in liquid cultures with enriched bone marrow progenitor cells before
1284
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Figure 2. IL-3 promotes BFU-E division and migration. (A) Subcolonies per colony. Mature (d14) erythroid colonies were examined
under 300X Hoffman contrast optics, and the numbers of subcolonies per colony were enumerated. 123 total GM-CSF-supported
erythroid colonies and 144 IL-3-supported colonies were examined.
(B) Day 3 cluster size. Erythroid progenitor cells were specifically
enriched by adding Leu 18 to the monoclonal antibody depletion
cocktail, and the number of undifferentiated blast cells per cell cluster enumerated after 3 d of methylcellulose culture. 108 total GMCSF-supported and 125 IL-3-supported clusters were analyzed, of
which 96% subsequently were found to be erythroid bursts, 1% myeloid colonies, and 3% multilineage (CFU-GEMM-derived) colonies.

short-term colony assays. Under these conditions, the induction of BFU-E self-renewal or commitment was assayed by the
appearance of more BFU-E-derived colonies in the subsequent cultures. Incubation of enriched progenitor cells in the
presence of GM-CSF sustained their survival for 72-96 h, allowing similar numbers of bursts to develop as observed in
cultures that were initiated before liquid culture. However,
there was no increase in BFU-E by preincubation with GMCSF. In contrast, preincubation in IL-3 led to increasing numbers of bursts in the subsequent semisolid colony assays. Liquid culture without GM-CSF or IL-3 led to the loss of all
subsequently clonable BFU-E (Fig. 3). This greater effect of
IL-3 versus GM-CSF on BFU-E proliferation in suspension
was observed over a wide range of concentrations of both recombinant hormones (Fig. 4), and was seen throughout the
time course of the culture at all concentrations. Thus, while
GM-CSF appeared to maintain numbers of BFU-E without
inducing division, IL-3 increased BFU-E either by actively
inducing self-renewal and expansion or by inducing differentiation from multilineage progenitors to BFU-E in liquid culture.

Stimulation of megakaryocyte colony formation with recombinant HGFs. Both IL-3 and GM-CSF supported the development of megakaryocyte colonies. Colony development
was limited with colonies being comprised of 3-50 relatively
immature cells. In each experiment IL-3 supported higher
numbers of megakaryocyte colonies than did GM-CSF (Table

BFU-E
per 103
Cells

Table IL Human Megakaryocyte Progenitor Cell
Responsiveness to IL-3

100
90
80
70
60
50

Donor (Exp. No.)

40
30
20
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0
0

1
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5

1. BICM
2. IL-3
100 pg/ml
1,000 pg/ml

7

Days in liquid Culture

Figure 3. IL-3 promotes BFU-E pool expansion in liquid culture: kinetics. Enriched bone marrow progenitor cells were cultured in liquid suspension in the presence of 1 ng/ml IL-3, 100 ng/ml GM-CSF,
or no added HGF for up to 7 d in liquid culture. Aliquots were removed, placed into methylcellulose cultures for 14 d, and erythroid
bursts enumerated. The data shown display the number of erythroid
bursts per 103 cells originally placed into liquid culture, and are from
one of three similar experiments.

II). Extended dose response experiments confirmed that this
increased megakaryocytopoietic effect of IL-3 was not due to
increased factor avidity alone, but also to a larger number of
susceptible CFU-Mk. The megakaryocytopoietic effect of
GM-CSF was maximal at 100-300 ng/ml, and was actually
substantially lower at 500 ng/ml (Fig. 5). No additive or synergistic effects between these two factors were observed in five
experiments over ranges of GM-CSF concentrations from 1 to
300 mg/ml and IL-3 concentration from 0.1 to 10 ng/ml.
Maximal megakaryocyte colony formation was always seen
with IL-3, and the simultaneous inclusion of GM-CSF and
IL-3 never stimulated the proliferation of more megakaryocytic colonies than did the same concentration of IL-3 alone

(Fig. 6).
Discussion
Both purified GM-CSF and IL-3 have distinct multilineage
colony stimulating activities, supporting the survival and proliferation of primitive BFU-E, CFU-GM, CFU-Mk, and multipotential CFU-GEMM. While GM-CSF supports greater
1000
900

% of

Input
BFU-E
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CFJ-Mk
Growth factor or
supematant

1.

2.

3.

X ± SD

40 18 18 25±13*

0 3 0 1±2
21 8 0 10±11
35 37 11 28±15
2,000pg/ml
3. GM-CSF (300 ng/ml) 20 3 5 9±9

1.

2.

3.

X±SD

92
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138

134±40*

93

29

72

65±32

83
43
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61
75
53

66
35
72

70±11
51±21
75±23

* CFU-Mk- and CFU-GM-derived colonies per I05 total nucleated cells cultured. Megakaryocyte progenitor cells were cultured as in Methods. Results for
each donor are means of three to five replicate cultures.

numbers of myeloid colonies than does IL-3, IL-3 has a
stronger proliferative effect on BFU-E and CFU-Mk, as well as
multilineage CFU-GEMM. The target cells for these studies
were enriched progenitor cells from which all known accessing
cells had been depleted. Cultures failed to generate colonies
when no added growth factor was added, suggesting that no
such activities were present in the cultures. Nevertheless, it is
indeed possible that some of the effects of GM-CSF and IL-3
were indirect effects mediated through intermediary cells or in
concert with costimulating hormones.
The greater burst-promoting activity of IL-3 is apparent
both in the number of bursts generated and in the size and
composition of the bursts. IL-3 stimulated the generation of
larger multicentric bursts than observed with GM-CSF. Close
examination of erythroid colony formation during the first 3 d
demonstrated that IL-3 exerted a stronger early proliferative
effect on BFU-E than does GM-CSF.
The greater proliferative effect of IL-3 was further demonstrated in the liquid culture incubations. During 3 d of liquid
culture, IL-3 increased the frequency of BFU-E, while GMCSF merely sustained input numbers of these cells. These data
suggest that IL-3 either stimulates self-renewal of BFU-E or,
alternatively, drives erythroid commitment from antecedent
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Figure 4. IL-3 promotes BFU-E pool expansion in liquid culture:
dose response. Enriched bone marrow progenitors were cultured in
suspension for 3 d before methylcellulose cultures, and BFU-E were
enumerated 14 d later, as in Fig. 3. The data shown are means±SD
of the number of erythroid bursts as a percentage of control cultures
plated in methylcellulose before suspension, and are from one of
four similar experiments.
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1010
lORECOMBINANT GROWTH FACTOR CONCENTRATION (grams/ml)

Figure 5. Comparative responsiveness of megakaryocyte progenitor
cells to IL-3 and GM-CSF. Progenitor cells cultured as in Methods.
Results are mean±SD of three to five replicate cultures (per concentration) of parallel cell cultures on a single donor, and are taken from
one of five similar experiments.
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Figure 6. Interaction
between IL-3 and GMCSF in megakaryocyte
colony formation.
Human enriched bone
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eloid lineages, GM-CSF would be expected to have a stronger
neutrophilic effect whereas IL-3 might have a stronger thrombopoietic effect. In clinical scenarios such as bone marrow
transplantation and chemotherapy-induced nadirs, combined
therapy with GM-CSF and IL-3 might be required for optimal
amelioration of neutrophil and platelet deficiency.
In summary, these data indicate that human recombinant
GM-CSF and IL-3 have overlapping but distinct spectra of
activities. These data further suggest that hematopoietic differentiation progresses through two parallel and loosely synchronized programs: the acquisition and loss of HGF responsiveness, and restriction to lineage commitment. Future clinical applications might take advantage of distinct activities to
achieve optimal benefits by combined treatment with both
hormones.
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